A U.S. Food and Drug Administration (FDA) advisory committee recently determined that phenylephrine, an ingredient commonly used to treat sinus and nasal congestion, is ineffective in treating these symptoms. This was apparent from research for years, yet large...
El senador estadounidense Marco Rubio (R-FL) habló con César Grajales de La Poderosa 670 AM en El Panorama Político, sobre la crisis fronteriza, sobre cómo los hispanoamericanos se ven afectados con la realidad del país, sobre los cargos contra el senador Bob Menéndez...
Pregnant students are sometimes discriminated against by their schools, either intentionally or unintentionally and there is a concerning lack of awareness about the resources and rights available to them. Due to a lack of services and discrimination, these women may...
Currently, intelligence community civilians are subject to certain tax penalties for job-related relocation requirements, but active-duty military servicemembers are not subjected to the same penalties. These tax benefits, including the ability to deduct moving...
Vice Chairman of the Senate Select Committee on Intelligence Marco Rubio (R-FL) delivered opening remarks and questioned witnesses at a hearing on countering China’s influence in the United States. Watch Rubio’s opening remarks here as well as Part I and Part II of...
Approximately 302,000 Americans live with spinal cord injuries. To help these people achieve a better quality of life, there is a need to increase education and invest in research. U.S. Senators Marco Rubio (R-FL) and Tammy Baldwin (D-WI) successfully led a bipartisan...
The Case for a Coronavirus Supply-Side Stimulus
Supply-side investment in businesses is where the government can most effectively step in to spur productive spending and fill the gap we’re experiencing today.
By U.S. Senator Marco Rubio (R-FL)
March 12, 2020
National Review
America’s economy is at risk of seizing up. The reason is not trouble in the credit markets or concerns about liquidity, but rather a collapse in demand stemming from fears of the coronavirus.
Washington sees this collapse in demand and responds only with proposals to put more money in the pockets of consumers.
That may be necessary, but no amount of consumer stimulus is going to offset the rational fears that people have of gathering in crowded spaces. Nor will it offset the economic impact of canceled conferences or events. Businesses that provide services are experiencing a demand shock due to the virus, so while throwing cash at them may keep them from going bankrupt, it will not be sufficient to stop an economic contraction.
…
Normally, U.S. manufacturers would respond to these targeted increases in demand by ramping up production — allowing manufacturers to keep up with consumers’ needs and distribute vital goods, all while helping to keep the economy afloat. The problem is that, thanks to decades of offshoring our industrial base, these sectors today simply lack the capacity to meet American demand.
…
The now-unfolding result is a vicious circle in which shortages prevent American consumers from accessing the medical goods and services they need to go out and participate in the economy.
Supply-side investment in businesses is where the government can most effectively step in to spur productive spending and fill the gap we’re experiencing today. With that assistance, businesses in areas not experiencing a coronavirus demand shock could increase production, which is what this country needs to avoid a recession or to quickly get out of one.
This, in short, is the supply-side case for stimulus. Increasing business spending where possible, especially in medical manufacturing, can help the economy produce more goods in a pinch and power through a contraction. Simply adopting strategies to offset falling consumer demand is a short-term measure that risks inflation.
Supply-side measures are no panacea, and should naturally be accompanied by other policies to mitigate the coronavirus pandemic. I have introduced a plan focused on reducing supply chain dependence on China, in particular in the production of pharmaceuticals and medical devices. In addition, I will be introducing legislation today in support of President Trump’s request that will provide the authorization for much-needed resources to the SBA’s 7(a) loan program.
…
Washington must act in the face of this pandemic. Failing to address the supply-side opportunities before us would leave the best opportunities for stimulus on the table. Acting now to rebuild our nation’s productive capacity is the right move for both the present and the future.
Read the rest here.